Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
---|
03/19/2009 | WO2009034258A1 Tri-amino-pyrimidine cyclobutenedione derivatives used as phosphatase cdc25 inhibitors |
03/19/2009 | WO2005076861A3 Compounds that inhibit hiv particle formation |
03/19/2009 | US20090076271 Process for preparing intermediates of HMG-CoA reductase inhibitors |
03/19/2009 | US20090076047 2-Substituted Hydroxylaminopyrimidine, Method for the Production and the Use Thereof in the Form of Pesticides |
03/19/2009 | US20090076046 Compounds modulating c-fms and/or c-kit activity and uses therefor |
03/19/2009 | US20090076045 Non-nucleoside reverse transcriptase inhibitors |
03/19/2009 | US20090076044 Vegfr inhibitors containing a zinc binding moiety |
03/19/2009 | US20090076043 Deuterium-enriched alfuzosin |
03/19/2009 | US20090076042 Deuterium-enriched erlotinib |
03/19/2009 | US20090076030 Piperazine compounds |
03/19/2009 | US20090076022 Tartrate salts of quinazoline based egfr inhibitors containing a zinc binding moiety |
03/19/2009 | US20090076005 Kinase inhibitor compounds |
03/19/2009 | US20090075986 Anti-inflammatory medicaments |
03/19/2009 | US20090075982 Piperazine compounds |
03/19/2009 | US20090075939 Novel HIV reverse transcriptase inhibitors |
03/19/2009 | US20090074887 For control of phytopathogenic fungi; synergistic |
03/19/2009 | CA2698944A1 Tartrate salts or complexes of quinazoline based egfr inhibitors containing a zinc binding moiety |
03/19/2009 | CA2692702A1 Tri-amino-pyrimidine cyclobutenedione derivatives used as phosphatase cdc25 inhibitors |
03/18/2009 | EP2036895A1 Hsp90 inhibitor |
03/18/2009 | EP2035406A1 Novel substituted-1h-quinazoline-2,4-dione derivatives, preparation method thereof and pharmaceutical composition containing the same |
03/18/2009 | EP2035401A2 Aryl- and heteroaryl-ethyl-acylguanidine derivatives, their preparation and their application in therapeutics |
03/18/2009 | EP2035370A2 Tetralin and indane derivatives and uses thereof |
03/18/2009 | EP1689380A4 Method for treating adamts-5-associated disease |
03/18/2009 | EP0963984B1 Heteroarylpiperidines and piperazines and their use as antipsychotics and analgetics |
03/18/2009 | CN101389612A 4-(3-benzoylaminophenyl)-6,7-dimethoxy-2- methylaminoquinazoline derivative |
03/18/2009 | CN101389611A Pyrimidinyl sulfonamide compounds which inhibit leukocyte adhesion mediated by vla-4 |
03/18/2009 | CN101386600A Process for producing phenylalanine derivative having quinazolinedione skeleton and intermediate for the same |
03/18/2009 | CN100469368C Use of adatanserin for treating neurogenerative disorders |
03/17/2009 | US7504512 BCL-X1 protein inhibitors; anticarcinogenic agents |
03/17/2009 | US7504503 Process for producing substituted aniline compound |
03/17/2009 | US7504502 Guanidinopyrimidinone compounds and phase change inks containing same |
03/17/2009 | US7504432 Quaternary salt of (3-((2-(3,3-difluorocyclopentyl)-2-hydroxy-2-(4-methylphenyl)ethanoyl)oxy)-1,1-dimethylpyrrolidinium bromide; respiratory system disorders; chronic obstructive pulmonary diseases, bronchitis, asthma, emphysema, rhinitis; side effect reduction; inhalants; muscarinic receptor antagonists |
03/17/2009 | US7504410 such as N-[3-[[5-bromo-4-[[3-[[[1-(trifluoromethyl)cyclobutyl]carbonyl]amino]propyl]amino]-2-pyrimidinyl]amino]phenyl]-1-pyrrolidinecarboxamide; Chks (checkpoint kinases), Akts (protein kinases B) and Pdks (phosphoinositide-dependent kinases) inhibitors; antiproliferative agents |
03/17/2009 | US7504408 Quinzoline derivatives for use in the treatment of cancer |
03/17/2009 | US7504405 Mitotic kinesin inhibitors |
03/17/2009 | US7504397 mTOR inhibitor compounds |
03/17/2009 | US7504396 Substituted heterocyclic compounds and methods of use |
03/17/2009 | US7504208 Deblocking, deprotecting 18F-labeled tracer; ion exchange chromatography; cartrigdes, radiopharmaceutical kits; diagnostic positron emission tomography; pharmacokinetics |
03/17/2009 | CA2639658A1 Design and synthesis of novel tubulin polymerization inhibitors: benzoylphenylurea (bpu) sulfur analogs |
03/17/2009 | CA2429263C Use of rosuvastatin (zd-4522) in the treatment of heterozygous familial hypercholesterolemia |
03/17/2009 | CA2340405C Substituted 4-amino-2-aryl-pyrimidines, their production and use and pharmaceutical preparations containing same |
03/12/2009 | WO2009032703A1 2- (het) arylamino-6-aminopyridine derivatives and fused forms thereof as anaplastic lymphoma kinase inhibitors |
03/12/2009 | WO2009032668A2 2 -biphenylamino-4 -aminopyrimidine derivatives as kinase inhibitors |
03/12/2009 | WO2009030715A1 Arylsulfonylaminomethylphosphonic acid derivatives, the preparation thereof and the use thereof as pharmaceutical compositions |
03/12/2009 | WO2009030467A2 Saturated and insaturated bi- or tricyclic aryloxyacetamide derivatives and their use as fungicides |
03/12/2009 | WO2009029998A1 Retrometabolic compounds |
03/12/2009 | WO2009010139A3 Quinazolinamide derivatives |
03/12/2009 | WO2009006086A3 A new process for preparing 2-(3-{6-[2-(2,4-dichlorophenyl)-ethylamino]-2-methoxypyrimidin-4-yl}-phenyl)- 2-methylpropionic acid |
03/12/2009 | WO2008155668A3 Heteroarylamide pyrimidone compounds |
03/12/2009 | US20090069563 Rosuvastatin intermediates and their preparation |
03/12/2009 | US20090069562 Process for the preparation of alfuzosin |
03/12/2009 | US20090069354 Deuterium-enriched gemcitabine |
03/12/2009 | US20090069353 Deuterium-enriched ambrisentan |
03/12/2009 | US20090069327 Compounds and compositions as protein kinase inhibitors |
03/12/2009 | US20090069320 Substituted 4-Amino-Quinazoline Compounds with Metabotropic Glutamate Receptor Regulating Activity and Uses Thereof |
03/12/2009 | US20090069310 Anti-inflammatory medicaments |
03/12/2009 | US20090069309 Prostaglandin analogs |
03/12/2009 | US20090069282 Alkyne compounds with mch antagonistic activity and medicaments comprising these compounds |
03/12/2009 | US20090068273 Prophylaxis of respiratory disorders such as asthma; composition with PDE4 inhibitor, corticosteroid hibitor or anticholinergic agent; 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol or salt |
03/12/2009 | US20090066231 Electroluminescent device |
03/12/2009 | US20090065739 Liquid crystal compound having chloronaphthalene moiety, liquid crystal composition, and optical device |
03/12/2009 | CA2698511A1 Substituted pyrimidinyl-amines as protein kinase inhibitors |
03/12/2009 | CA2698486A1 Arylsulfonylaminomethylphosphonic acid derivatives, the preparation thereof and the use thereof as pharmaceutical compositions |
03/12/2009 | CA2696824A1 Compounds and compositions as kinase inhibitors |
03/12/2009 | CA2696320A1 Novel fungicides |
03/11/2009 | EP2033950A1 Substituted tetracycline compounds |
03/11/2009 | EP2033647A1 Agent against psychosocial stresses |
03/11/2009 | EP2033637A1 Therapeutic or prophylactic agent for leukemia |
03/11/2009 | EP2032554A1 Piperidinyl pyrimidine derivatives |
03/11/2009 | EP2032543A1 2-anilino-4-aminoalkyleneaminopyrimidines |
03/11/2009 | EP2032542A2 Heterocyclic aspartyl protease inhibitors |
03/11/2009 | EP1631533B1 Novel process for stereoselective reduction of beta-ketoesters |
03/11/2009 | EP1485364B1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
03/11/2009 | EP1456182B1 Pyrimidine derivatives as modulators of insuline-like growth factor-1 receptor (igf-i) |
03/11/2009 | EP1349840B1 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto |
03/11/2009 | EP0976722B1 Benzamidine derivatives |
03/11/2009 | CN101384562A 2-substituted pyrimidines and their use as pesticides |
03/11/2009 | CN101384561A Reduction of 5-(aryl-diazenyl)-4,6-dihalo-pyrimidine |
03/11/2009 | CN101384554A Pyridine-2-carboxamide derivatives |
03/11/2009 | CN101381347A Miazines compounds, preparation method and use thereof |
03/11/2009 | CN100467447C Thioamide compound or its salt and cytokine production inhibitor containing the same |
03/10/2009 | US7501512 Chemical compounds |
03/10/2009 | US7501510 N,N'-disubstituted thiourea ligand, when complexed with palladium forms a catalyst useful for Heck reaction of arylhalides and olefins and Suzuki cross-coupling reaction of aryl halides with aryl boric acids |
03/10/2009 | US7501429 Pyrimidine compounds as anti-ictogenic and/or anti-epileptogenic agents |
03/10/2009 | US7501428 Quinazoline thiazolinones |
03/10/2009 | US7501427 Such as N6-(4,5-dihydrooxazol-2-yl)-N4-[3-methyl-4-(6-methylpyridin-3-yloxy)-phenyl]-quinazoline-4,6-diamine; for treatment of hyperproliferative disorders such as cancer |
03/10/2009 | US7501425 e.g. 1-Methyl-7-[4-(pyrazol-1-yl)phenylamino]pyrimido[4,5-d]pyrimidin-2(1H)-one; anticarcinogenic agents; restenosis, angiogenesis and atherosclerosis |
03/10/2009 | US7501424 4-methyl-N-(5-methylthiazol-2-yl)-3-(4-thiazol-2-yl-pyrimidin-2-ylamino)-benzamide; amidation; protein kinase inhibitor; water soluble; stability; anticancer; Chronic Myelogenous Leukemia; lung, gastric, colon, pancreatic, hepatoma, prostatic, breast, encephalophyma, bladder, cervical, lymphoma |
03/10/2009 | US7501418 e.g. 3-[4-(2-Methyl-3-phenyl-allyl)-piperazin-1-ylmethyl]-3a,4-dihydro-3H-2,5-dioxa-1,7-diaza-dicyclopenta[a,g]naphthalene; serotonine (5-HT) reuptake inhibitor, alpha 2-adrenoceptor antagonist; antidepressant, anxiolytic agent; Parkinson's disease, eating disorders, psychosis, obesity |
03/10/2009 | US7501417 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
03/10/2009 | US7501416 Quinoxaline compounds and methods of using them |
03/10/2009 | US7501407 Amide substituted pyrimidine compound; antiarthritic agents; antiischemic agents; antidiabetic agents; inflammatory bowel disease; antiproliferative agents; antiallergens |
03/05/2009 | WO2009029735A1 2-(substituted phenyl)-6-amino-5-alkoxy, thioalkoxy and aminoalkyl-4-pyrimidinecarboxylates and their use as herbicides |
03/05/2009 | WO2009027450A1 Novel bradykinin b1-antagonists |
03/05/2009 | WO2008142720A4 Quinazolin-oxime derivatives as hsp90 inhibitors |
03/05/2009 | WO2008062276A3 Acetylene derivatives as stearoyl coa desaturase inhibitors |
03/05/2009 | WO2008055068A3 Inhibitors of histone deacetylase |
03/05/2009 | US20090062539 Crystals, amorphous substances or salts of methyl n-[3-(6,7-dimethoxy-2-methylaminoquinazolin-4-yl) phenyl] terephthalamic acid |
03/05/2009 | US20090062536 Use of sulfonanilide compounds as herbicide |
03/05/2009 | US20090062530 Substituted arylalkanoic acid derivatives and use thereof |